Inadequate humoral immunogenicity to recombinant hepatitis B virus vaccine in biliary atresia children

Pediatric Research

Volumn 64, Issue 1, 2008, Pages 100-104

  Wu, Jia Feng ^a   Ni, Yen Hsuan ^a,b   Chen, Huey Ling ^a   Hsu, Hong Yuan ^a   Lai, Hong Shiee ^a   Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; MEMBRANE ANTIGEN; RECOMBINANT VACCINE;

ARTICLE; BILE DUCT ATRESIA; CHILD; CHILDHOOD; CLINICAL EVALUATION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; VIRUS CORE; ANTIBODY PRODUCTION; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; IMMUNOLOGY; NUTRITIONAL STATUS; TIME;

ANTIBODY FORMATION; BILIARY ATRESIA; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; NUTRITIONAL STATUS; TIME FACTORS; VACCINES, SYNTHETIC;

EID: 49849105003     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181732908     Document Type: Article

References (21)

1. Hoofnagle JH 2004 Biliary atresia research consortium (BARC). Hepatology 39:891
2. Hung PY, Chen CC, Chen WJ, Lai HS, Hsu WM, Lee PH, Ho MC, Chen TH, Ni YH, Chen HL, Hsu HY, Chang MH 2006 Long-term prognosis of patients with biliary atresia: a 25 year summary. J Pediatr Gastroenterol Nutr 42:190-195
3. Sokal EM, Ulla L, Otte JB 1992 Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Dig Dis Sci 37:1250-1252
4. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, Shih YT 1987 A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597-2603
5. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS 1996 Seroepi- demiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276:906-908
6. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS 2001 Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796-800
7. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS 2007 Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for further strategies. Gastroenterology 132:12871293
8. Ho MC, Wu YM, Hu RH, Ko WJ, Yang PM, Lai MY, Lin MH, Lin HY, Lee PH 2004 Surgical complications and outcome of living related liver transplantation. Transplant Proc 36:2249-2251
9. Lin CC, Chen CL, Concejero A, Wang CC, Wang SH, Liu YW, Yang CH, Yong CC, Lin TS, Chiang YC, Jawan B, Huang TL, Cheng YF, Eng HL 2007 Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant 7:195-200
10. Taylor RM, Cheeseman P, DavenportM, Tizzard SA, Goldblatt D, Mieli-Vergani G, Hadzic N 2003 Humoral immunity in children with biliary atresia splenic malformation syndrome. Eur J Pediatr 162:539-540
11. Collier AC, Corey L, Murphy VL, Handsfield HH 1988 Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109:101-105
12. Wu JF, Chiang BL, Chen HL, Lai HS, Chang MH, Ni YH 2006 Impaired T lymphocyte proliferation function in biliary atresia patients with chronic cholestatic jaundice after a Kasai operation. Pediatr Res 60:602-606
13. Rosenthal P, Wong V, Ross LA, Kim KS 1990 Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies. J Pediatr Gastroenterol Nutr 11:201-204
14. Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM 2005 Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int 9:367-375
15. Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, Weesner RE, Morgan DD 1988 Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci 33:263-269
16. Veiga AP, Casseb J, Duarte AJ 2006 Humoral response to hepatitis B vaccination and its relationship with T CD45RA+(naïve) and CD45RO +(memory) subsets in HIV-1-infected subjects. Vaccine 24:7124-7128
17. Parks RW, Halliday MI, McCrory DC, Erwin P, Smye M, Diamond T, Rowlands BJ 2003 Host immune responses and intestinal permeability in patients with jaundice. Br J Surg 90:239-245
18. Thompson RL, Ranjbar S, Rowlands BJ 1993 T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors. World J Surg 17:783-785
19. Law DK, Dudrick SJ, Abdou NI 1973 Immunocompetence of patients with protein- calorie malnutrition. Ann Intern Med 79:545-550
20. Shih HH, Chang MH, Hsu HY, Lee PI, Ni YH, Chen DS 1999 Long-term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Pediatr Infect Dis J 18:427-432
21. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS 2003 Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 187:134 -138